Disruptive Technologies Innovation Fund
VC Fund
Dublin, Ireland
Disruptive Technologies Innovation Fund is a VC fund in Dublin focused on Health Care and Medical Device. The Disruptive Technologies Innovation Fund is a €500 million fund established under Project Ireland 2040 and is run by the Department of Business, Enterprise and Innovation with administrative support from Enterprise Ireland.
- Total investments:
- 56
- Last investment:
- Lead investor:
- 95%
Last updated:
For AI agents: llms.txt
Industries Disruptive Technologies Innovation Fund invests in
Stages Disruptive Technologies Innovation Fund invests in
Countries Disruptive Technologies Innovation Fund invests in
Round sizes
Round size
- Grant
- $1.7M–$10M
- Venture - Series Unknown
- $11M–$11M
Investment Focus
Industry
- Health Care 21 (38%)
- Medical Device 19 (34%)
- Medical 14 (25%)
- Biotechnology 10 (18%)
- Education 7 (13%)
Stage
- Grant 49 (88%)
- Venture - Series Unknown 2 (4%)
- Seed 1 (2%)
- Series A 1 (2%)
- Funding Round 1 (2%)
Country
- Ireland 47 (84%)
- United Kingdom 1 (2%)
- The Netherlands 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CroíValve
|
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation | $7M / Grant / Jun 23, 2026 | |
HT Materials Science
|
HT Materials Science provides nanofluid science in thermal systems for commercial and industrial infrastructure. | $2.6M / Grant / Dec 17, 2025 | |
Rockfield Medical Devices
|
Rockfield Medical Devices is an innovative SME in the area of human centered design process in the medical device industry.The company is led by its founder and has a very strong team made up of several acknowledged experts from the medical device industry and from research and design.Rockfield aims to be a leading innovator in the enteralfeeding market globally and strives to achieve exemplary end user satisfaction with their plug and play technologies through innovative design, usability and mobility. | $3.8M / Grant / Dec 08, 2025 | |
ÉireComposites
|
ÉireComposites provides design, tooling, manufacturing, and testing to the international aerospace industry. It is also involved in production and R&D in the rapidly growing area of renewable energy, specifically in composite turbine blades and nacelles.The company is delivering composite components and assemblies for international aerospaceprogrammes, and participates in important European Union R&D programmes in the aerospace sector.It has world-leading proprietary technology and know-how in thermoplastic composites, from glass-fibre polypropylene (Twintex®) to advanced carbon-fibre thermoplastics such as PEEK and PEKK and has particular expertise in moulding of new liquid-moulded thermoplastic resins such as CBT®, APLC-12 and APLC-6. | $4.4M / Grant / Dec 08, 2025 | |
FeelTect
|
FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous. | $7.3M / Grant / Dec 08, 2025 | |
Fortis Medical Devices
|
Fortis Medical Devices is a healthcare company that offers medical device designed to help patients with Parkinson's disease. | $2.9M / Grant / Oct 08, 2025 | |
ProVascTec
|
ProVascTec, a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system and form a natural bypass around arterial occlusions in the peripheral vascular system, particularly below the knee. The paracrine process of stem cells is used by ProVascTec, a preclinical stage cell treatment firm, to stimulate thedevelopment of a novel circulatory system and form a natural bypass around arterial occlusions in the peripheral vascular system, particularly below the knee. | $2.9M / Grant / Sep 25, 2025 | |
GlasPort Bio
|
GlasPort Bio is a biotechnology company based in Galway, Ireland where it has its research laboratories and offices. The key focus of GlasPort Bio is to maximise the efficiency of natural resources, deriving value streams from a variety of materials, often those deemed as waste. Their technologies help to unlock ‘hidden’ commercial potential whileallowing for a host of environmental benefits. We aim to play a key role in a fully integrated bio-based economy, allowing stakeholders transition to low carbon economies. GlasPort Bio is built upon over 10 years of research and development and has developed a range of innovative technologies for applications in multiple fields including agriculture, agri-food, green energy and biotechnology. | Grant / Sep 25, 2025 | |
Plio Surgical
|
Plio Surgical is a firm in the Medical Devices industry. | $4.5M / Grant / Sep 25, 2025 | |
University of Galway
|
The University of Galway provides high-quality instruction and a worldwide influence on research. | Grant / Sep 25, 2025 | |
| See all 56 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Disruptive Technologies Innovation Fund invest in?
Disruptive Technologies Innovation Fund invests primarily in Health Care, Medical Device and Medical startups, most often at Grant and Venture - Series Unknown stage. Most of the 56 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Disruptive Technologies Innovation Fund's check size?
Disruptive Technologies Innovation Fund typically joins rounds of $1.7M–$10M at Grant and $11M–$11M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Disruptive Technologies Innovation Fund participates in.
When did Disruptive Technologies Innovation Fund last invest?
The most recent investment recorded for Disruptive Technologies Innovation Fund closed in Jun 2026. Shizune tracks 56 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
